287 related articles for article (PubMed ID: 20660184)
21. Impact of HLA-B*52:01-Driven Escape Mutations on Viral Replicative Capacity.
Tsai MC; Singh S; Adland E; Goulder P
J Virol; 2020 Jun; 94(13):. PubMed ID: 32321820
[TBL] [Abstract][Full Text] [Related]
22. Protective HLA alleles are associated with reduced LPS levels in acute HIV infection with implications for immune activation and pathogenesis.
Claiborne DT; Scully EP; Palmer CD; Prince JL; Macharia GN; Kopycinski J; Michelo CM; Wiener HW; Parker R; Nganou-Makamdop K; Douek D; Altfeld M; Gilmour J; Price MA; Tang J; Kilembe W; Allen SA; Hunter E
PLoS Pathog; 2019 Aug; 15(8):e1007981. PubMed ID: 31449552
[TBL] [Abstract][Full Text] [Related]
23. Human leukocyte antigen class I supertypes and HIV-1 control in African Americans.
Lazaryan A; Song W; Lobashevsky E; Tang J; Shrestha S; Zhang K; Gardner LI; McNicholl JM; Wilson CM; Klein RS; Rompalo A; Mayer K; Sobel J; Kaslow RA; ;
J Virol; 2010 Mar; 84(5):2610-7. PubMed ID: 20032191
[TBL] [Abstract][Full Text] [Related]
24. Possession of HLA class II DRB1*1303 associates with reduced viral loads in chronic HIV-1 clade C and B infection.
Julg B; Moodley ES; Qi Y; Ramduth D; Reddy S; Mncube Z; Gao X; Goulder PJ; Detels R; Ndung'u T; Walker BD; Carrington M
J Infect Dis; 2011 Mar; 203(6):803-9. PubMed ID: 21257739
[TBL] [Abstract][Full Text] [Related]
25. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection.
Altfeld M; Addo MM; Rosenberg ES; Hecht FM; Lee PK; Vogel M; Yu XG; Draenert R; Johnston MN; Strick D; Allen TM; Feeney ME; Kahn JO; Sekaly RP; Levy JA; Rockstroh JK; Goulder PJ; Walker BD
AIDS; 2003 Dec; 17(18):2581-91. PubMed ID: 14685052
[TBL] [Abstract][Full Text] [Related]
26. Frequent human leukocyte antigen class I alleles are associated with higher viral load among HIV type 1 seroconverters in Thailand.
Nguyen L; Chaowanachan T; Vanichseni S; McNicholl JM; Mock PA; Nelson R; Hodge TW; van Griensven F; Choopanya K; Mastro TD; Tappero JW; Hu DJ
J Acquir Immune Defic Syndr; 2004 Oct; 37(2):1318-23. PubMed ID: 15385741
[TBL] [Abstract][Full Text] [Related]
27. Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines.
Kaslow RA; Rivers C; Tang J; Bender TJ; Goepfert PA; El Habib R; Weinhold K; Mulligan MJ;
J Virol; 2001 Sep; 75(18):8681-9. PubMed ID: 11507213
[TBL] [Abstract][Full Text] [Related]
28. Accumulation of Pol Mutations Selected by HLA-B*52:01-C*12:02 Protective Haplotype-Restricted Cytotoxic T Lymphocytes Causes Low Plasma Viral Load Due to Low Viral Fitness of Mutant Viruses.
Murakoshi H; Koyanagi M; Chikata T; Rahman MA; Kuse N; Sakai K; Gatanaga H; Oka S; Takiguchi M
J Virol; 2017 Feb; 91(4):. PubMed ID: 27903797
[TBL] [Abstract][Full Text] [Related]
29. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
[TBL] [Abstract][Full Text] [Related]
30. Changes in impact of HLA class I allele expression on HIV-1 plasma virus loads at a population level over time.
Koga M; Kawana-Tachikawa A; Heckerman D; Odawara T; Nakamura H; Koibuchi T; Fujii T; Miura T; Iwamoto A
Microbiol Immunol; 2010 Apr; 54(4):196-205. PubMed ID: 20377748
[TBL] [Abstract][Full Text] [Related]
31. Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART).
Dold L; Ahlenstiel G; Althausen E; Luda C; Schwarze-Zander C; Boesecke C; Wasmuth JC; Rockstroh JK; Spengler U
PLoS One; 2015; 10(8):e0134158. PubMed ID: 26241854
[TBL] [Abstract][Full Text] [Related]
32. Immunogenetic factors in early immune control of human immunodeficiency virus type 1 (HIV-1) infection: Evaluation of HLA class I amino acid variants in two African populations.
Wiener HW; Shrestha S; Lu H; Karita E; Kilembe W; Allen S; Hunter E; Goepfert PA; Tang J
Hum Immunol; 2018 Mar; 79(3):166-171. PubMed ID: 29289742
[TBL] [Abstract][Full Text] [Related]
33. Impact of polymorphisms in the HCP5 and HLA-C, and ZNRD1 genes on HIV viral load.
Thørner LW; Erikstrup C; Harritshøj LH; Larsen MH; Kronborg G; Pedersen C; Larsen CS; Pedersen G; Gerstoft J; Obel N; Ullum H
Infect Genet Evol; 2016 Jul; 41():185-190. PubMed ID: 27083073
[TBL] [Abstract][Full Text] [Related]
34. HLA-Bw4-B*57 and Cw*18 alleles are associated with plasma viral load modulation in HIV-1 infected individuals in Salvador, Brazil.
Silva EM; Acosta AX; Santos EJ; Netto EM; Lemaire DC; Oliveira AS; Barbosa CM; Bendicho MT; Galvão-Castro B; Brites C
Braz J Infect Dis; 2010; 14(5):468-75. PubMed ID: 21221475
[TBL] [Abstract][Full Text] [Related]
35. Rapid human immunodeficiency virus disease progression is associated with human leukocyte antigen-B homozygocity and human leukocyte antigen-B51 in a cohort from Manitoba, Canada.
Keynan Y; Becker M; Rueda Z; Bresler K; Kasper K
Infect Dis (Lond); 2015 Jul; 47(7):447-52. PubMed ID: 25746818
[TBL] [Abstract][Full Text] [Related]
36. HLA class I associations with rates of HIV-1 seroconversion and disease progression in the Pumwani Sex Worker Cohort.
Peterson TA; Kimani J; Wachihi C; Bielawny T; Mendoza L; Thavaneswaran S; Narayansingh MJ; Kariri T; Liang B; Ball TB; Ngugi EN; Plummer FA; Luo M
Tissue Antigens; 2013 Feb; 81(2):93-107. PubMed ID: 23330720
[TBL] [Abstract][Full Text] [Related]
37. Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity.
Flores-Villanueva PO; Yunis EJ; Delgado JC; Vittinghoff E; Buchbinder S; Leung JY; Uglialoro AM; Clavijo OP; Rosenberg ES; Kalams SA; Braun JD; Boswell SL; Walker BD; Goldfeld AE
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5140-5. PubMed ID: 11309482
[TBL] [Abstract][Full Text] [Related]
38. The influence of human leukocyte antigen class I alleles and their population frequencies on human immunodeficiency virus type 1 control among African Americans.
Lazaryan A; Song W; Lobashevsky E; Tang J; Shrestha S; Zhang K; McNicholl JM; Gardner LI; Wilson CM; Klein RS; Rompalo A; Mayer K; Sobel J; Kaslow RA; ;
Hum Immunol; 2011 Apr; 72(4):312-8. PubMed ID: 21262311
[TBL] [Abstract][Full Text] [Related]
39. Co-operative additive effects between HLA alleles in control of HIV-1.
Matthews PC; Listgarten J; Carlson JM; Payne R; Huang KH; Frater J; Goedhals D; Steyn D; van Vuuren C; Paioni P; Jooste P; Ogwu A; Shapiro R; Mncube Z; Ndung'u T; Walker BD; Heckerman D; Goulder PJ
PLoS One; 2012; 7(10):e47799. PubMed ID: 23094091
[TBL] [Abstract][Full Text] [Related]
40. Human leukocyte antigen B distribution in HIV discordant cohort from India.
Chaudhari DV; Chavan VR; Ahir SP; Kerkar SC; Mehta PR; Mania-Pramanik J
Immunol Lett; 2013; 156(1-2):1-6. PubMed ID: 24029662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
